Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pseudomonas exotoxin (domains II/III)-Interleukin 13 chimeric protein

EU orphan designation number: EU/3/02/101   
Active ingredient: Pseudomonas exotoxin (domains II/III)-Interleukin 13 chimeric protein
Indication: Treatment of glioma
Sponsor: EUDRAC Limited
Hampden House, Monument Business Park, Chalgrove, OX44 7RW United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/05/2002 Centralised Orphan - Designation EMEA/OD/004/02 (2002)1832 of 30/04/2002
17/02/2012 Centralised Orphan - Transfer of orphan designation EMEA/OD/004/02/T/01 (2012)1103 of 15/02/2012